of the listed company or of the listed company and its subsidiaries collectively, as the case may be. The size of the transaction is equal to 17.93 percent when including the value of transactions of
provide any service or limit scope of providing services. Clause 37 An intermediary shall review or adjust received information as prescribed in Clause 31 to be current at reasonable time or when it appears
Derivatives Intermediaries (No. 7) dated 9 February 2017 (effective on 16 February 2017). 16 Clause 37 An intermediary shall review or adjust received information as prescribed in Clause 31 to be current at
Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales
ongoing outbreak of COVID–19, forcing many customers to adjust their working method which have an effect on the operation and delivery of the Company's projects that cause the operation to be delayed than
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
benefit expenses For Quarter 2 of the year 2020, the management benefit was 3.24 million baht compare to 3.77 million baht, decrease by 0.53 million or 14.06% decreased because the company had adjust the
materially cut down sales expenses from the previous year in alignment with the drop in sales revenue. Nevertheless, some of the sales expenses took time to adjust and did not fully reflect the slowdown in
to revenues and salary & benefits of staff decreased due to cost saving policy by proper human resource management. Cost saving plan will be more effective starting 2Q/2020 One-time expenses For the